The treatment of EAMG mice with recombinant human tumor necrosis factor receptor soluble protein (TNFR) Fc blocking endogenous TNF can relieve the symptoms of asthenia, but cannot inhibit the serum anti-AChR antibodies [38]. Here, TNF is linked to asthenia.